Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico
Clinical trials sponsored by Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico, explained in plain language.
-
Cancer drug combo tested for rare skin cancer – but study never started
Disease control TerminatedThis study aimed to test a combination of two drugs, pembrolizumab and lenvatinib, in people with classic Kaposi sarcoma whose cancer had returned or not responded to prior chemotherapy. The goal was to see if the combination could shrink tumors better than standard chemotherapy.…
Phase: PHASE2 • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Disease control
Last updated Jun 17, 2026 03:25 UTC
-
Which hormone combo do women with endometriosis like best? new study aims to find out
Symptom relief OngoingThis study looks at two different hormone treatments for endometriosis, a condition that causes pelvic pain and infertility. Both treatments combine a progestin with a natural estrogen patch. The goal is to see which one women are more satisfied with after 6 months. The study inv…
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Symptom relief
Last updated Jun 15, 2026 18:56 UTC
-
Massive hospital study tracks hidden kidney danger
Knowledge-focused OngoingThis study looks at medical records from 43,000 hospitalized patients to find out how often acute kidney injury (AKI) happens during a hospital stay. Researchers will also see how AKI affects patients' chances of recovery, readmission, and survival. The goal is to better understa…
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:54 UTC